The Warnings and Precautions sections for healthcare professionals for Mounjaro and Trulicity were updated to notify doctors that Events related to impaired gastric emptying, including severe gastroparesis, have been reported and to Monitor and consider dose modification or discontinuation in patients who develop severe gastrointestinal symptoms while on treatment . The Patient Medical Information for both drugs was also updated to add language to alert users that Stomach problems, sometimes severe, have been reported in people who use the drugs and that patients should Tell your healthcare provider if you have stomach problems that are severe or will not go away. Siskinds is assisting Canadians who have been harmed by GLP-1 drugs Siskinds is seeking to recover compensation for Canadians suffering severe stomach issues and other serious health issues resulting from their use of prescription GLP-1 drugs, such as Ozempic, Rybelsus, Wegovy, Trulicity, and Mounjaro
However, the complexity of their mechanisms and the lack of comprehensive studies on their long-term safety and efficacy necessitate further research
These risks can be listed as follows: Although rare, some people may experience mild allergic reactions such as redness and stomach cramps
How to reconstitute BPC-157 (injectable powder) Step-by-step guide to mixing your BPC-157 powder
175 Gene therapy strategies have been shown to be able to correct the PK-deficient phenotype in mice
El-Gizawy MM, Hosny EN, Mourad HH, Abd-El Razik AN
